CSL Of Australia, Baxter Of U.S. Sued In U.S. Courts For Plasma Prices
This article was originally published in PharmAsia News
Executive Summary
Australia's CSL is the target of a U.S. federal suit filed by 11 hospitals that allege CSL and U.S-based Baxter International engaged in fixing the price of blood plasma